HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Efficacy of huperzine in preventing soman-induced seizures, neuropathological changes and lethality.

Abstract
Huperzine A (HUP) is a potent reversible inhibitor of acetylcholinesterase (AChE) that crosses the blood-brain barrier. Its ability to prevent seizures and subsequent hippocampal neuropathological changes induced by the organophosphate soman was studied in guinea pigs. Results were compared to guinea pigs treated with pyridostigmine (PYR, 0.2 mg/kg, subcutaneously). HUP pretreatment at 0.5 mg/kg, intraperitoneally, totally prevented seizures and ensured the survival of all animals for 24 h after intoxication. Hippocampal tissue was then free of any neuronal damage. Comparatively, all animals pretreated with PYR exhibited epileptic activity after soman poisoning and five of six animals died. Examination of the hippocampus of the only surviving guinea pig pretreated with PYR showed extensive neuropathological changes. Although HUP or PYR induced similar inhibitions of blood AChE activity, only HUP pretreatment led to a decrease in central AChE activity. In binding studies on guinea-pig brain homogenates, HUP had no affinity for muscarinic, alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) and gamma-aminobutyric acid (GABA)A receptors and only a very low one for N-methyl-D-aspartate (NMDA) receptors. In conclusion, HUP, unlike PYR, protects against soman-induced convulsions and neuropathological changes in the hippocampus. This efficacy seems to be related to a protection by HUP of both peripheral and central stores of AChE.
AuthorsG Lallement, J Veyret, C Masqueliez, S Aubriot, M F Burckhart, D Baubichon
JournalFundamental & clinical pharmacology (Fundam Clin Pharmacol) Vol. 11 Issue 5 Pg. 387-94 ( 1997) ISSN: 0767-3981 [Print] England
PMID9342591 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Alkaloids
  • Cholinesterase Inhibitors
  • Neuroprotective Agents
  • Receptors, N-Methyl-D-Aspartate
  • Sesquiterpenes
  • huperzine A
  • Soman
  • Pyridostigmine Bromide
Topics
  • Alkaloids
  • Animals
  • Brain (metabolism)
  • Cholinesterase Inhibitors (metabolism, therapeutic use)
  • Electroencephalography
  • Guinea Pigs
  • Hippocampus (pathology)
  • Male
  • Neuroprotective Agents (therapeutic use)
  • Pyridostigmine Bromide (therapeutic use)
  • Receptors, N-Methyl-D-Aspartate (metabolism)
  • Seizures (chemically induced, drug therapy, pathology)
  • Sesquiterpenes (metabolism, therapeutic use)
  • Soman

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: